The key to a successful DCT is a superior patient experience, as it directly impacts compliance and retention.
TORONTO (PRWEB) September 02, 2021
The adoption of decentralized clinical trials (DCTs) has increased over the past 18 months due to the COVID-19 pandemic. The digitization of clinical trials has revealed numerous benefits to both study sponsors and patients, including streamlining of clinical operations, reducing patient and investigator burden, accelerating clinical trial timelines, and increasing patient diversity, compliance and retention. With the advantages of DCTs so apparent, studies are left looking for new ways to capture medical-grade data remotely and securely.
The key to a successful DCT is a superior patient experience, as it directly impacts compliance and retention. In this webinar, AliveCor will deliver real-world examples of DCTs, showing how implementing user-friendly digital health devices improves overall patient experience while simultaneously providing study sites with easily accessible, medical-grade, health data.
Join Craig H. Lipset, Founder, Clinical Innovation Partners; Dr. Todd Rudo, Deputy Chief Medical Officer at ERT; and Aman H.Bhatti, MD, Vice President of Global Medical Affairs & Head of BioPharma, AliveCor in a live webinar on Wednesday, September 22, 2021 at 1pm EDT.
For more information, or to register for this event, visit How to Reinvent and Scale Decentralized Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.